Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,556 | -4,932 | -20,302 | -26,839 | -13,816 |
| Depreciation Amortization | 107 | 84 | 15 | 15 | 15 |
| Accounts receivable | 734 | -733 | 5 | -12 | 10 |
| Accounts payable and accrued liabilities | -3,887 | 6,047 | 661 | 249 | -1,406 |
| Other Working Capital | -1,907 | 7,053 | -3,532 | -391 | -2,282 |
| Other Operating Activity | 3,340 | -31,646 | -592 | 14,493 | 9,729 |
| Operating Cash Flow | $-28,171 | $-24,126 | $-23,745 | $-12,484 | $-7,750 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,316 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -457 | N/A | N/A | N/A |
| Purchase Of Investment | -330 | -225 | N/A | N/A | N/A |
| Investing Cash Flow | $-7,646 | $-682 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 216 |
| Debt Repayment | N/A | N/A | N/A | N/A | -307 |
| Common Stock Issued | 45,448 | 4,419 | 4,002 | 6,510 | 65,328 |
| Common Stock Repurchased | N/A | N/A | -47 | -10,172 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -81 | -239 |
| Financing Cash Flow | $45,448 | $4,419 | $3,954 | $-3,743 | $64,998 |
| Beginning Cash Position | 862 | 21,251 | 41,042 | 57,269 | 21 |
| End Cash Position | 10,494 | 862 | 21,251 | 41,042 | 57,269 |
| Net Cash Flow | $9,632 | $-20,389 | $-19,791 | $-16,227 | $57,247 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,171 | -24,126 | -23,745 | -12,484 | -7,750 |
| Capital Expenditure | N/A | -457 | N/A | N/A | N/A |
| Free Cash Flow | -28,171 | -24,583 | -23,745 | -12,484 | -7,750 |